Literature DB >> 19208573

Pulmonary abnormalities in patients with early and longstanding rheumatoid arthritis.

Athanasios N Georgiadis, Zafiria M Metafratzi, Alexandros A Drosos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19208573     DOI: 10.3899/jrheum.080882

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  5 in total

1.  Anti-citrullinated heat shock protein 90 antibodies identified in bronchoalveolar lavage fluid are a marker of lung-specific immune responses.

Authors:  Lisa Harlow; Bernadette R Gochuico; Ivan O Rosas; Tracy J Doyle; Juan C Osorio; Timothy S Travers; Carlos C Camacho; Chester V Oddis; Dana P Ascherman
Journal:  Clin Immunol       Date:  2014-08-19       Impact factor: 3.969

2.  Methotrexate and interstitial lung disease. Is there a real causative factor?

Authors:  E Pelechas; A N Georgiadis; P V Voulgari; A A Drosos
Journal:  Rheumatol Int       Date:  2021-05-27       Impact factor: 2.631

3.  Interstitial lung disease in rheumatoid arthritis.

Authors:  Dana P Ascherman
Journal:  Curr Rheumatol Rep       Date:  2010-10       Impact factor: 4.592

Review 4.  Rheumatoid Arthritis-Associated Interstitial Lung Disease: Current Concepts.

Authors:  Yoel Brito; Marilyn K Glassberg; Dana P Ascherman
Journal:  Curr Rheumatol Rep       Date:  2017-11-09       Impact factor: 4.592

5.  Duration of rheumatoid arthritis and the risk of developing interstitial lung disease.

Authors:  Michael P Mohning; Isabelle Amigues; M Kristen Demoruelle; Evans R Fernández Pérez; Tristan J Huie; Rebecca K Keith; Amy L Olson; Zulma X Yunt; Jonathan H Chung; Stephen Hobbs; Jeffrey J Swigris; Joshua J Solomon
Journal:  ERJ Open Res       Date:  2021-02-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.